Literature DB >> 28804605

Up-regulation of miR-21 decreases chemotherapeutic effect of dendrosomal curcumin in breast cancer cells.

Mohammad Javad Dehghan Esmatabadi1, Baharak Farhangi1, Maryam Montazeri2, Hamideh Monfared1, Roohollah Nakhaei Sistani3, Majid Sadeghizadeh1.   

Abstract

OBJECTIVES: Despite the good results of anticancer activities by curcumin, there are some hurdles that limit the use of curcumin as an anticancer agent. Many methods were examined to overcome this defect like the use of the dendrosomal curcumin (DNC). There is increasing evidence that miRNAs play important roles in biological processes. In this study, we focus on the roles of microRNA-21 in the anti-cancer effects of DNC in breast cancer.
MATERIALS AND METHODS: Also, we have used different methods such as MTT, apoptosis, cell cycle analysis, transwell migration assay and RT-PCR to find out more.
RESULTS: We observed that miR-21 decreased apoptotic cells in both cells (from 6.35% to 0.34 % and from 7.72% to 1.32% orderly) and DNC increased it. As well as, our findings indicated that cell migration capacity was increased by miR-21 over expression and was decreased by DNC. The combination of miR-21 vector transfection and DNC treatment showed lower percentage of apoptotic cells or a higher level of penetration through the membrane compared with DNC treatment alone. Furthermore, DNC induced a marked increase in the number of cells in sub G1/G1 phase and a decrease in G2/M phase of the cell cycle in both; but, we observed reverse results compared it, after transfection with miR-21 vector.
CONCLUSION: We observed that miR-21 suppress many aspects of anti-cancer effects of DNC in breast cancer cells, it seems that co-treatment with DNC and mir-21 down-regulation may provide a clinically useful tool for drug-resistance breast cancer cells.

Entities:  

Keywords:  Breast cancer; Cell cycle; Cell proliferation; Curcumin; Dendrosomal curcumin; MicroRNA-21

Year:  2017        PMID: 28804605      PMCID: PMC5425916          DOI: 10.22038/IJBMS.2017.8574

Source DB:  PubMed          Journal:  Iran J Basic Med Sci        ISSN: 2008-3866            Impact factor:   2.699


  53 in total

Review 1.  Regulating miRNA by natural agents as a new strategy for cancer treatment.

Authors:  Sajiv Sethi; Yiwei Li; Fazlul H Sarkar
Journal:  Curr Drug Targets       Date:  2013-09       Impact factor: 3.465

2.  MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression.

Authors:  Bao Song; Chuanxi Wang; Jie Liu; Xingwu Wang; Liyan Lv; Ling Wei; Li Xie; Yan Zheng; Xianrang Song
Journal:  J Exp Clin Cancer Res       Date:  2010-03-27

Review 3.  Discovery of curcumin, a component of golden spice, and its miraculous biological activities.

Authors:  Subash C Gupta; Sridevi Patchva; Wonil Koh; Bharat B Aggarwal
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-03       Impact factor: 2.557

4.  Chemoprevention of azoxymethane-initiated colon cancer in rat by using a novel polymeric nanocarrier--curcumin.

Authors:  Ali Mohammad Alizadeh; Mahmood Khaniki; Saleh Azizian; Mohammad Ali Mohaghgheghi; Majid Sadeghizadeh; Farhood Najafi
Journal:  Eur J Pharmacol       Date:  2012-06-16       Impact factor: 4.432

5.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

6.  Protective effects of dendrosomal curcumin on an animal metastatic breast tumor.

Authors:  Baharak Farhangi; Ali Mohammad Alizadeh; Hamid Khodayari; Saeed Khodayari; Mohammad Javad Dehghan; Vahid Khori; Alemeh Heidarzadeh; Mahmood Khaniki; Majid Sadeghiezadeh; Farhood Najafi
Journal:  Eur J Pharmacol       Date:  2015-04-08       Impact factor: 4.432

7.  MicroRNA expression profiles in head and neck cancer cell lines.

Authors:  Nham Tran; Tessa McLean; Xiaoying Zhang; Chuan Jia Zhao; John Michael Thomson; Christopher O'Brien; Barbara Rose
Journal:  Biochem Biophys Res Commun       Date:  2007-04-09       Impact factor: 3.575

Review 8.  Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.

Authors:  Ajaikumar B Kunnumakkara; Preetha Anand; Bharat B Aggarwal
Journal:  Cancer Lett       Date:  2008-05-13       Impact factor: 8.679

9.  Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.

Authors:  Subramanian Kumar; Ranganathan Keerthana; Annamalai Pazhanimuthu; Pachiappan Perumal
Journal:  Indian J Biochem Biophys       Date:  2013-06       Impact factor: 1.918

10.  Patterns of known and novel small RNAs in human cervical cancer.

Authors:  Weng-Onn Lui; Nader Pourmand; Bruce K Patterson; Andrew Fire
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

View more
  5 in total

1.  MicroRNA-214 inhibits the proliferation and invasion of lung carcinoma cells by targeting JAK1.

Authors:  Xiaofeng Chen; Jiangyuan Du; Rui Jiang; Ling Li
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

2.  Induction of Apoptosis and Regulation of MicroRNA Expression by (2E,6E)-2,6-bis-(4-hydroxy-3-methoxybenzylidene)-cyclohexanone (BHMC) Treatment on MCF-7 Breast Cancer Cells.

Authors:  Swee Keong Yeap; Norlaily Mohd Ali; Muhammad Nadeem Akhtar; Nursyamirah Abd Razak; Zhi Xiong Chong; Wan Yong Ho; Lily Boo; Seema Zareen; Tonni Agustiono Kurniawan; Ram Avtar; Stephanie Y L Ng; Alan Han Kiat Ong; Noorjahan Banu Alitheen
Journal:  Molecules       Date:  2021-02-26       Impact factor: 4.411

3.  Curcumin inhibits proliferation, migration, invasion and promotes apoptosis of retinoblastoma cell lines through modulation of miR-99a and JAK/STAT pathway.

Authors:  Yaping Li; Weixuan Sun; Ning Han; Ying Zou; Dexin Yin
Journal:  BMC Cancer       Date:  2018-12-10       Impact factor: 4.430

4.  miR-21 protects against lipopolysaccharide-stimulated acute kidney injury and apoptosis by targeting CDK6.

Authors:  Wei Wei; Yuan-Yuan Yao; Hong-Yuan Bi; Zhe Zhai; Yan Gao
Journal:  Ann Transl Med       Date:  2020-03

Review 5.  Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Authors:  Alexandru A Sabo; Maria Dudau; George L Constantin; Tudor C Pop; Christoph-M Geilfus; Alessio Naccarati; Mihnea P Dragomir
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.